UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

New perspectives on targeted therapy in ovarian cancer

International journal of women's health, 2015-01, Vol.7 (default), p.189-203

2015

Link zum Volltext

Verfügbarkeit prüfen

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

The lancet oncology, 2023-08, Vol.24 (8), p.925-935

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3023-3023

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B12: Examining EGFR-mediated PI3K/Akt pathway in combination therapy of cetuximab and dynamin inhibition

Molecular cancer research, 2020-10, Vol.18 (10_Supplement), p.B12-B12

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT3-24-01: ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT3-24-01-OT3-24-01

2023

Link zum Volltext

Verfügbarkeit prüfen

The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2006-12, Vol.54 (3), p.371-377

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.211-221

2015

Link zum Volltext

Verfügbarkeit prüfen

Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function

FASEB bioAdvances, 2019-08, Vol.1 (8), p.498-510

2019

Link zum Volltext

Verfügbarkeit prüfen

Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists

Bioorganic & medicinal chemistry letters, 2014-01, Vol.24 (1), p.156-160

2014

Link zum Volltext

Verfügbarkeit prüfen

Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists

Bioorganic & medicinal chemistry letters, 2013-06, Vol.23 (12), p.3609-3613

2013

Link zum Volltext

Verfügbarkeit prüfen

FO033PODOCYTE SPECIFIC GLYCOGEN SYNTHASE KINASE 3 IS CRITICAL FOR KIDNEY FUCTION IN DEVELOPMENT AND MATURITY

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii17-iii17

2015

Link zum Volltext

Verfügbarkeit prüfen

Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (4), p.1133-1137

2014

Link zum Volltext

Verfügbarkeit prüfen

The Routledge Companion to Death and Dying

1, 2018

Link zum Volltext

Verfügbarkeit prüfen

CLINICAL OUTCOMES OF A STAPLED ILEAL NEOBLADDER AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER

The Journal of urology, 2009, Vol.181 (4), p.267-268

2009

Link zum Volltext

Verfügbarkeit prüfen

Rankin Inlet ceramics

Winnipeg, Manitoba: Winnipeg Art Gallery, 2003, ISBN: 0889152241, 2003

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Humans
(6)
Animals
(3)
Chemistry
(3)
Chemistry, Medicinal
(3)
Chemistry, Organic
(3)
Chemotherapy
(3)
Drug Discovery
(3)
Female
(3)
Male
(3)
Oncology
(3)
Pharmacology & Pharmacy
(3)
Physical Sciences
(3)
Receptors, G-Protein-Coupled - Agonists
(3)
Structure-Activity Relationship
(3)
Aged
(2)
Aged, 80 And Over
(2)
Agonists
(2)
Cancer
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New perspectives on targeted therapy in ovarian cancer

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study

Abstract B12: Examining EGFR-mediated PI3K/Akt pathway in combination therapy of cetuximab and dynamin inhibition

Abstract OT3-24-01: ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer

The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial

Podocyte GSK3α is important for autophagy and its loss detrimental for glomerular function

Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists

Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists

FO033PODOCYTE SPECIFIC GLYCOGEN SYNTHASE KINASE 3 IS CRITICAL FOR KIDNEY FUCTION IN DEVELOPMENT AND MATURITY

Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists

The Routledge Companion to Death and Dying

CLINICAL OUTCOMES OF A STAPLED ILEAL NEOBLADDER AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER

Rankin Inlet ceramics

Suchergebnisse filtern